Solventum Corporation is a healthcare company.
Solventum Corporation (SOLV) is expected to report earnings on Thursday, November 5, 2026, after the close. Estimated release time 16:12 ET. Consensus EPS estimate is $1.35.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2025-08-08 | FY2025 Q2 | $1.45 | $0.52 | -64.1% | $2.16B |
| 2025-05-09 | FY2025 Q1 | $1.21 | $0.79 | -34.7% | $2.07B |
| 2024-11-08 | FY2024 Q3 | $1.39 | $0.70 | -49.6% | $2.08B |
| 2024-05-10 | FY2024 Q1 | $1.75 | $1.37 | -21.7% | $2.02B |
| 2023-12-31 | FY2023 Q4 | $0.00 | $1.57 | — | $2.04B |
| 2023-09-30 | FY2023 Q2 | — | $2.66 | — | $2.07B |
| 2023-06-30 | FY2023 Q1 | — | $1.86 | — | $2.08B |
| 2023-03-31 | FY2022 Q4 | — | $1.70 | — | $2.01B |
SOLV has beaten consensus EPS in 0 of its last 8 reported quarters.
See SOLV on the live calendar →